Accelerating Breakthrough Discoveries into Medicines

2013 Scholar-Innovators

2013 Harrington Scholar-Innovators Lead the Way in Medical Innovation

The 2013 Harrington Scholar-Innovators were selected by the Harrington Discovery Institute’s Scientific Advisory Board from a field of more than 130 applicants from 53 institutions.

Marc Diamond, MD
Washington University in St. Louis

Marc Diamond, MD

Dr. Diamond’s research focuses on the development of new treatments for Alzheimer's disease and other types of dementia.

Read More

Roger Greenberg, MD/PhD
University of Pennsylvania

Roger Greenberg, MD/PhD

Dr. Greenberg’s laboratory focuses on the creation of a new class of drugs to prevent breast and ovarian cancer.

Read More

Geoffrey Gurtner, MD
Stanford University

Geoffrey Gurtner, MD

Dr. Gurtner’s research is concerned with the development of a topical drug to heal wounds, particularly in people with diabetes.

Read More

Richard Kitsis, MD
Albert Einstein College of Medicine

Richard Kitsis, MD

Dr. Kitsis’s research is focused on the creation of a first-in-class drug to reduce heart cell damage from heart attacks.

Read More

Wolfgang Liedtke, MD/PhD
Duke University

Wolfgang Liedtke, MD/PhD

Dr. Liedtke is focused on the development of a new class of drugs that inhibit the pain response in skin.

Read More

Sanford Markowitz, MD/PhD
Case Western Reserve University

Sanford Markowitz, MD/PhD

Dr. Markowitz’s research is concerned with the discovery of a compound that increases natural protective substances in tissues to help with liver regeneration and number of human diseases including pulmonary hypertension and cancer.

Read More

Scott Oakes, MD
University of California, San Francisco

Scott Oakes, MD

Dr. Oakes is focused on the discovery of a novel life-death switch that has led to new drugs for Lou Gehrig’s disease, diabetes and multiple myeloma.

Read More

Feroz R. Papa, MD, PhD
University of California-San Francisco

Feroz R. Papa, MD, PhD

Dr. Papa’s research focuses on molecular, cellular and organismal approaches to address broad questions revolving around protein misfolding and cell degenerative diseases.

Read More

Jonathan Powell, MD/PhD
Johns Hopkins University

Jonathan Powell, MD/PhD

Dr. Powell’s research focuses on the development of a class of drugs to treat diabetes and obesity by lowering bad cholesterol and glucose and generating good fat.

Read More

Larry Schlesinger, MD
Ohio State University

Larry Schlesinger, MD

Dr. Schlesinger is researching a new class of anti-tuberculosis drugs that will prevent the development of drug resistance.

Read More

Robert Wilson, MD/PhD
University of Pennsylvania

Robert Wilson, MD/PhD

Dr. Wilson’s research is concerned with the identification of a new class of drugs that treat all types of cancer.

Read More

Harrington Project

The Harrington Discovery Institute is the nonprofit arm of the Harrington Project for Discovery & Development, an international initiative supporting breakthrough research by physician-scientists. The Project is a new and powerful approach to address some of the challenges hindering advancement of medicine today.

The Harrington Grant is an important part of the overall pharmaceutical research initiative created by The Harrington Project.